Proximagen announces positive efficacy results in NIH epilepsy studies
15-Mar-2010 -
Proximagen Neuroscience plc announced headline results from the successful completion of a year-long non-clinical testing programme undertaken by the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institute of Health (NIH) in the United States, which confirm ...
drug development
epilepsy
neurological disorders
+4